SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARESE, Mattia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.003
EU - Europa 2.850
AS - Asia 2.090
SA - Sud America 288
AF - Africa 61
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.926
FI - Finlandia 1.922
SG - Singapore 779
CN - Cina 524
IT - Italia 241
VN - Vietnam 232
BR - Brasile 223
DE - Germania 159
HK - Hong Kong 155
GB - Regno Unito 93
PL - Polonia 75
JP - Giappone 71
ID - Indonesia 67
TR - Turchia 67
FR - Francia 66
UA - Ucraina 65
RU - Federazione Russa 47
IN - India 41
CA - Canada 39
SE - Svezia 39
MX - Messico 33
AR - Argentina 26
BD - Bangladesh 22
NO - Norvegia 22
PK - Pakistan 22
IQ - Iraq 19
CZ - Repubblica Ceca 17
ES - Italia 17
NL - Olanda 17
ZA - Sudafrica 17
BE - Belgio 15
EC - Ecuador 12
IR - Iran 12
AT - Austria 10
KE - Kenya 10
VE - Venezuela 10
MA - Marocco 9
SA - Arabia Saudita 9
IE - Irlanda 8
LT - Lituania 8
MY - Malesia 8
UZ - Uzbekistan 8
CL - Cile 7
KR - Corea 7
DK - Danimarca 6
IL - Israele 6
PT - Portogallo 6
AZ - Azerbaigian 5
CO - Colombia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
GE - Georgia 4
PH - Filippine 4
TH - Thailandia 4
AL - Albania 3
JO - Giordania 3
NP - Nepal 3
PY - Paraguay 3
AU - Australia 2
BH - Bahrain 2
CR - Costa Rica 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 8.295
Salva come PNG Salva come JPEG
Città #
Helsinki 1.907
Singapore 513
Ashburn 372
Chandler 212
San Jose 207
Fairfield 195
Santa Clara 180
Beijing 173
Hong Kong 147
Woodbridge 131
Dallas 113
Ferrara 112
Council Bluffs 91
New York 91
Seattle 90
Ho Chi Minh City 80
Houston 80
Los Angeles 71
Wilmington 71
Warsaw 69
Cambridge 67
Ann Arbor 64
Tokyo 61
Jakarta 57
Munich 57
Hanoi 54
Izmir 47
Jacksonville 43
Princeton 43
Shanghai 43
Nanjing 37
Dearborn 34
Lauterbourg 33
São Paulo 28
Milan 27
Bremen 22
Denver 20
Orem 20
London 16
Oslo 16
Mexico City 15
Montreal 15
Moscow 15
Nanchang 15
Brooklyn 14
Chicago 14
Poplar 14
Brno 13
Toronto 13
Boardman 12
Falkenstein 12
Guangzhou 12
Lahore 12
Redwood City 12
Rio de Janeiro 12
San Diego 12
Da Nang 11
Phoenix 11
The Dalles 11
Atlanta 10
Brussels 10
Dong Ket 10
Manchester 10
Rome 10
Shenyang 10
Bologna 9
Hebei 9
Johannesburg 9
Tianjin 9
Baghdad 8
Frankfurt am Main 8
Haiphong 8
Jiaxing 8
Nairobi 8
Chennai 7
Kyiv 7
Mumbai 7
Stockholm 7
Tashkent 7
Turku 7
Zhengzhou 7
Amsterdam 6
Copenhagen 6
Fairford 6
Indore 6
Kunming 6
Nuremberg 6
Piemonte 6
Quito 6
San Francisco 6
Santiago 6
Andover 5
Belo Horizonte 5
Boston 5
Ferrara di Monte Baldo 5
Jinan 5
Paris 5
Ribeirão Preto 5
Riyadh 5
San Mateo 5
Totale 6.229
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.041
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 297
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 295
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 241
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 238
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 226
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 208
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 202
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 202
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 196
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 182
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 180
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 177
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 174
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 174
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 163
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 161
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 161
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 160
Protein engineering and pharmacological approaches to develop novel treatment strategies for coagulation disorders 160
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 157
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 157
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 154
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 152
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 152
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 152
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 151
An advanced method for the small-scale production of high-quality minicircle DNA 146
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 142
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 138
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 135
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 135
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 132
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 121
Next generation factor VIIa with enhanced half-life 115
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 98
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains 98
null 93
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 92
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 86
Totale 8.444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 0 0 0 0 66 51 41
2021/2022358 59 35 8 4 21 22 5 12 17 31 21 123
2022/2023436 48 61 12 62 62 50 30 31 42 5 18 15
2023/2024285 10 23 16 4 17 61 15 30 6 9 12 82
2024/20251.124 36 20 97 29 130 167 20 23 178 103 181 140
2025/20264.784 299 181 229 415 460 222 374 183 2.138 283 0 0
Totale 8.444